| CRISPR Medicine | This is an overview of our interviews
Dual CAR-T cells incorporating an IF/THEN logic-gated system show enhanced anti-tumour cytotoxicity and reduced off-tumour effects in mouse models....
Researchers used large language models (LLMs) to expand the sequence diversity of CRISPR-Cas proteins and generate novel, functional genome editors...
Three research groups recently independently elucidated the genetic and epigenetic mechanisms driving prostate cancer metastasis. The innovative use...
GlaxoSmithKline Pharma’s Fiona Behan explores synthetic lethality and complex drivers of cancer to identify new therapeutic targets.
Two research groups are independently pioneering a groundbreaking gene-editing treatment for severe immunodeficiencies, potentially transforming the...
In a recent study, researchers in Germany used CRISPR/Cas9 nickases to develop a gene therapy approach, termed MILESTONE, to treat severe congenital...
In a recent study, researchers in Italy addressed the critical need for experimental validation of durable epigenetic silencing after transient...
Founded in 2018, Vivlion is a spin-out of Goethe University Frankfurt. Its mission is to provide innovative gene-editing reagents and screening...
